Holen Sie sich die Stockscreener-App
9.94
3.68%
-0.38
Handel nachbörslich:
10.34
0.40
+4.02%
Schlusskurs vom Vortag:
$10.32
Offen:
$10.33
24-Stunden-Volumen:
564.40K
Relative Volume:
2.21
Marktkapitalisierung:
$328.83M
Einnahmen:
$65.42M
Nettoeinkommen (Verlust:
$-32.96M
KGV:
-7.8268
EPS:
-1.27
Netto-Cashflow:
$-19.87M
1W Leistung:
+0.81%
1M Leistung:
+20.48%
6M Leistung:
-15.40%
1J Leistung:
+34.51%
1-Tages-Spanne:
$9.90
$10.38
1-Wochen-Bereich:
$9.65
$10.38
52-Wochen-Spanne:
$5.45
$18.98
Neuropace Inc Stock (NPCE) Company Profile
Firmenname
Neuropace Inc
Sektor
Branche
Telefon
(650) 237-2700
Adresse
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Vergleichen Sie NPCE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
9.94 | 341.40M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-21 | Eingeleitet | UBS | Buy |
| 2024-03-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-08-24 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | Eingeleitet | Lake Street | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-01-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-05-17 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-05-17 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Neuropace Inc Aktie (NPCE) Neueste Nachrichten
Will NeuroPace Inc. outperform the marketWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Is NeuroPace Inc. building a consolidation baseInsider Selling & Short-Term Swing Trade Alerts - newser.com
NeuroPace Inc. stock prediction for this weekPortfolio Gains Report & Safe Entry Zone Identification - newser.com
Forecasting NeuroPace Inc. price range with options data2025 Short Interest & Target Return Focused Stock Picks - newser.com
NeuroPace, Inc. (NASDAQ:NPCE) Looks Just Right With A 25% Price Jump - simplywall.st
Using Vision Transformers for Electrographic Seizure Classification to Aid Physician Review of Intracranial Electroencephalography Recordings - Frontiers
How to recover losses in NeuroPace Inc. stock2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
Why NeuroPace Inc. is moving todayTrade Analysis Summary & Stepwise Trade Signal Guides - newser.com
NeuroPace, Inc. (NASDAQ:NPCE) Receives $16.60 Consensus Target Price from Analysts - MarketBeat
Aug Sectors: What makes NeuroPace Inc stock attractive today2025 Key Lessons & Fast Momentum Entry Tips - خودرو بانک
Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Price Target at $16.60 - Defense World
Will NeuroPace Inc. stock recover after earningsMarket Movement Recap & Short-Term High Return Ideas - khodrobank.com
NeuroPace to Participate in Upcoming Healthcare Conferences - Investing News Network
NeuroPace raises FY25 revenue view to $94M-$98M, consensus $94.78M - MSN
Jacobs Levy Equity Management Inc. Has $637,000 Stock Position in NeuroPace, Inc. $NPCE - Defense World
NeuroPace, Inc.'s (NASDAQ:NPCE) Intrinsic Value Is Potentially 99% Above Its Share Price - Yahoo Finance
NeuroPace stock remains Cantor Fitzgerald’s top pick for 2025 By Investing.com - Investing.com Nigeria
NeuroPace stock remains Cantor Fitzgerald’s top pick for 2025 - Investing.com
NeuroPace Inc. Moves Into Overbought Range Analysts CautiousEarnings Growth Report & Free Safe Entry Trade Signal Reports - beatles.ru
NeuroPace Inc. Stock Fails to Break Resistance Traders React2025 Institutional Moves & Real-Time Volume Analysis Alerts - beatles.ru
First Light Asset Management LLC Buys New Position in NeuroPace, Inc. $NPCE - MarketBeat
Ghisallo Capital Management LLC Invests $2.46 Million in NeuroPace, Inc. $NPCE - MarketBeat
Nantahala Capital Management LLC Sells 249,979 Shares of NeuroPace, Inc. $NPCE - MarketBeat
Inflation Data: Can Super Micro Computer Inc. maintain sales growthJuly 2025 Decliners & Community Consensus Trade Signals - خودرو بانک
Armistice Capital LLC Increases Stock Holdings in NeuroPace, Inc. $NPCE - MarketBeat
NeuroPace Inc. stock trendline breakdownWeekly Investment Report & Weekly Watchlist of Top Performers - Newser
Bear Alert: Is NeuroPace Inc. still a buy after recent gainsJuly 2025 Analyst Calls & Trade Opportunity Analysis - خودرو بانک
Statistical indicators supporting NeuroPace Inc.’s strengthLong Setup & Safe Capital Growth Stock Tips - Newser
Volume spikes in NeuroPace Inc. stock – what they meanJuly 2025 Sentiment & Fast Moving Stock Watchlists - Newser
803,440 Shares in NeuroPace, Inc. $NPCE Acquired by Driehaus Capital Management LLC - MarketBeat
What to expect from NeuroPace Inc. in the next 30 days2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - Newser
Treasury Yields: Can NeuroPace Inc. stock double in the next yearJuly 2025 Gainers & Stock Timing and Entry Methods - خودرو بانک
What are analysts’ price targets for NeuroPace Inc.July 2025 Review & Stepwise Trade Execution Plans - خودرو بانک
NeuroPace, Inc. Reports Record Revenue and Strong Margins in Q2 2025 Earnings Call - MSN
Can NeuroPace Inc. hit a new high this monthJuly 2025 Selloffs & Free High Return Stock Watch Alerts - Newser
Russell Investments Group Ltd. Acquires New Holdings in NeuroPace, Inc. $NPCE - MarketBeat
Price momentum metrics for NeuroPace Inc. explainedEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - Newser
Finanzdaten der Neuropace Inc-Aktie (NPCE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):